Public-registry site landscape for NCT03837457, a Cutaneous T-Cell Lymphoma/Mycosis Fungoides study sponsored by miRagen Therapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03837457 (registry record) |
| Sponsor | miRagen Therapeutics, Inc. |
| Condition(s) | Cutaneous T-Cell Lymphoma/Mycosis Fungoides |
| Phase | PHASE2 |
| Listed sites | 9 |
| Site countries | United States, Belgium, France |
Eichor generates a preliminary site-risk snapshot for NCT03837457 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →